Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-2.57
Price to sales ratio
111.44

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
2742
VSTM
Verastem, Inc. - Common Stock
7.38 USD-0.14%+7.27%+18.27%-20.30%668.36 M USD
2743
SGMT
Sagimet Biosciences Inc. - Series A Common Stock
10.75 USD-1.01%+5.19%+47.46%+42.20%668.21 M USD
2751
MDXG
MiMedx Group, Inc - Common Stock
4.51 USD+2.04%+4.88%+3.44%-37.19%657.38 M USD
2764
CRMD
CorMedix Inc. - Common Stock
8.31 USD-0.95%+0.24%+12.91%-26.46%647.72 M USD

Frequently asked questions about Prime Medicine, Inc. Common Stock

What is the Prime Medicine, Inc. Common Stock stock price today?

The current price of Prime Medicine, Inc. Common Stock (PRME) is 3.64. Over the past 24 hours, the stock has changed by +1.68%. Follow the PRME chart for real-time price dynamics.

What is the stock ticker of Prime Medicine, Inc. Common Stock?

Prime Medicine, Inc. Common Stock trades under the ticker PRME. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Prime Medicine, Inc. Common Stock stock going up?

PRME has changed by +10.98% over the last week, +18.57% over the last month, and +5.20% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Prime Medicine, Inc. Common Stock?

Prime Medicine, Inc. Common Stock currently has a market capitalization of 660.21 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

Does Prime Medicine, Inc. Common Stock release financial reports?

Yes. You can track Prime Medicine, Inc. Common Stock financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.

What were Prime Medicine, Inc. Common Stock earnings last quarter?

Last quarter, Prime Medicine, Inc. Common Stock reported earnings of -0.24 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was Prime Medicine, Inc. Common Stock net income for the last quarter?

Prime Medicine, Inc. Common Stock reported net income of -42.11 M for the last quarter. The previous quarter showed -49.12 M, which means net income changed by +14.28%.

How many employees does Prime Medicine, Inc. Common Stock have?

As of the latest available data, Prime Medicine, Inc. Common Stock has 146 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Prime Medicine, Inc. Common Stock stock?

You can buy Prime Medicine, Inc. Common Stock (PRME) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Prime Medicine, Inc. Common Stock stock?

Investing in Prime Medicine, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the PRME chart and related analysis on metatrader.com as part of your research.

Prime Medicine, Inc. - Common Stock

Prime Medicine, Inc. is an American biotechnology company developing gene therapies based on prime editing. The company is headquartered in Cambridge, Massachusetts.

News